|
[1]
|
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDC Wkly 2020;2(8):113 − 22. http://dx.doi.org/10.46234/ccdcw2020.032CrossRef
|
|
[2]
|
Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020;76:71 − 6. http://dx.doi.org/10.1016/j.ijsu.2020.02.034CrossRef
|
|
[3]
|
COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet 2022;399(10344):2351 − 80. http://dx.doi.org/10.1016/S0140-6736(22)00484-6CrossRef
|
|
[4]
|
De la Rosa-Zamboni D, Ortega-Riosvelasco F, González-García N, Gamiño-Arroyo AE, Espinosa-González GA, Valladares-Wagner JM, et al. Tracing COVID-19 source of infection among health personnel in a pediatric hospital. Front Pediatr 2022;10:897113. http://dx.doi.org/10.3389/fped.2022.897113CrossRef
|
|
[5]
|
Piazza MF, Amicizia D, Marchini F, Astengo M, Grammatico F, Battaglini A, et al. Who is at higher risk of SARS-CoV-2 reinfection? Results from a northern region of Italy. Vaccines (Basel) 2022;10(11):1885. http://dx.doi.org/10.3390/vaccines10111885CrossRef
|
|
[6]
|
COVID-19 Forecasting Team. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. Lancet 2022;399(10334):1469 − 88. http://dx.doi.org/10.1016/S0140-6736(21)02867-1CrossRef
|
|
[7]
|
Nealon J, Cowling BJ. Omicron severity: milder but not mild. Lancet 2022;399(10323):412 − 3. http://dx.doi.org/10.1016/S0140-6736(22)00056-3CrossRef
|
|
[8]
|
Manai MV, Shaholli D, La Torre G. Contact tracing as an essential prevention tool for the spreading of COVID-19 among healthcare workers. Clin Ter 2022;173(5):396 − 7. http://dx.doi.org/10.7417/CT.2022.2452CrossRef
|
|
[9]
|
Mensah AA, Lacy J, Stowe J, Seghezzo G, Sachdeva R, Simmons R, et al. Disease severity during SARS-CoV-2 reinfection: a nationwide study. J Infect 2022;84(4):542 − 50. http://dx.doi.org/10.1016/j.jinf.2022.01.012CrossRef
|
|
[10]
|
Nguyen NN, Houhamdi L, Hoang VT, Delerce J, Delorme L, Colson P, et al. SARS-CoV-2 reinfection and COVID-19 severity. Emerg Microbes Infect 2022;11(1):894 − 901. http://dx.doi.org/10.1080/22221751.2022.2052358CrossRef
|